Fig. 2From: Antidiabetic efficacy of lactoferrin in type 2 diabetic pediatrics; controlling impact on PPAR-γ, SIRT-1, and TLR4 downstream signaling pathwayProtein levels of NrF2/ARE (a), NFkB (b) in diabetic pediatrics with/without lactofrrin treatment, compared to the control cohortsBack to article page